Define an Executable Process: Vulnerability Inputs, Screening, and Risk Assessment
“If a process is not executable it doesn’t do anyone any good” explained Abrahamson. There are many identifiable vulnerabilities out there, so it is important to translate them into a list that is actionable by the product engineering team. For example, if you have a list of a thousand vulnerabilities that may affect the device, a manufacturer is not going to know what to do with that. You have to put in place a mechanism to identify which vulnerabilities are potentially impactful. From there you can work with the engineering team to create a process that determines what the risk level is, and where you have to take action.
While it is important make an actionable plan with any manufacturer, when dealing with a larger manufacturer, that might have hundreds of products and tens of thousands of devices, you have to really consider scalability. Anything that makes sense at an individual vulnerability level must be scaled to hundreds of vulnerabilities on tens of thousands of devices.
Implementation: Training, Communication, Operating Mechanisms, and Continual Improvement
When it comes to implementation, anything you do must be viewed as part of a system. Cybersecurity is an area that many medical device manufacturers, and people within the manufactures organizations, are not familiar with. As you implement new practices to address risks, it is important to make sure people understand what they are, have clear definitions of the processes, and go through a formal implementation. Like any well-executed system, training, communication, and operating mechanisms are key elements to ensure a smooth transition.
A cybersecurity system is very analogous to a quality system. The approach that can be taken in a quality system can also be translated when looking at security requirements. There has to be a mechanism in place to measuring effectiveness, and continual improvement.
Conclusion
When creating a postmarket surveillance cybersecurity strategy, there are many considerations that must be made. At the Global Postmarket Surveillance of Medical Device conference on January 18-19, 2018 in Arlington, VA leaders from the industry will meet to discuss best practices regarding lifecycle approaches to ensuring product safety and compliance.